1. 435 Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes. (September 2015) Authors: Hodgson, D.R.; Dougherty, B.; Lai, Z.; Grinsted, L.; Spencer, S.; O'Connor, M.J.; Ho, T.W.; Robertson, J.D.; Lanchbury, J.; Timms, K.; Gutin, A.; Orr, M.; Jones, H.; Gilks, B.; Womack, C.; Sun, J.; Yelensky, R.; Gourley, C.; Ledermann, J.; Barrett, J.C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antitumor activity of the WEE1 inhibitor AZD1775 as a monotherapy and in combination with the PARP inhibitor olaparib in patient-derived explant (PDX) models. (December 2016) Authors: O'Connor, M.J.; Odedra, R.; Palakurthi, S.; Hughes, A.; Lai, Z.; Kirschmeier, P.; Zeng, Q.; Zhou, S.; Dharma, S.; Ivanova, E.; Wang, A.; Pierce, A.J.; Yates, J.; Powell, S.; Dougherty, B.; Barrett, J.C.; English, J.; Jewsbury, P.; Matulonis, U.A.; Liu, J.F. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Identification of an effective chemotherapy and DNA damage response inhibitor combination for diffuse large b cell lymphoma. (October 2022) Authors: Chan, A.; Anbuselvan, A.; Upadhyayula, S.S.; Jemimah, S.; Jaynes, P.; Hoppe, M.M.; Wardyn, J.D.; Goh, J.; Bertolazzi, G.; Foiani, M.; O'Connor, M.J.; Chow, E.K.; Tripodo, C.; Jeyasekharan, A.D. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Lack of RAD51 foci formation enables the identification of PARP inhibitor sensitive breast tumors. (December 2016) Authors: Castroviejo-Bermejo, M.; Cruz, C.; Guerra, S.; Llop-Guevara, A.; Gutiérrez-Enríquez, S.; Bruna, A.; Rubio, I.T.; Oakin, A.; Nucíforo, P.; Díez, O.; Arribas, J.; Judde, J.G.; Caldas, C.; Baselga, J.; Cortés, J.; Balmaña, J.; Saura, C.; O'Connor, M.J.; Cairo, S.; Serra, V. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC-0617: The PARP inhibitor olaparib is effective as radiosensitizer at 10-fold lower doses than as single agent. (April 2015) Authors: De Haan, R.; Verhagen, C.V.M.; Hageman, F.; Oostendorp, T.; Di Carli, A.; O'Connor, M.J.; Jonkers, J.; Van Triest, B.; Van den Brekel, M.W.M.; Verheij, M.; Vens, C. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗